Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility

BACKGROUND: Subependymal giant cell astrocytoma (SEGA) is occasionally seen in tuberous sclerosis complex (TSC). Two main options are currently available for treating SEGA: surgical resection or pharmacotherapy using mammalian target of rapamycin inhibitors (mTORi). We hypothesized that opportunitie...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomoto, Kyoichi, Fujimoto, Ayataka, Inenaga, Chikanori, Okanishi, Tohru, Imai, Shin, Ogai, Masaaki, Fukunaga, Akiko, Nakamura, Hidenori, Sato, Keishiro, Obana, Akira, Masui, Takayuki, Arai, Yoshifumi, Enoki, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011204/
https://www.ncbi.nlm.nih.gov/pubmed/33784976
http://dx.doi.org/10.1186/s12883-021-02160-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011204/
https://www.ncbi.nlm.nih.gov/pubmed/33784976
http://dx.doi.org/10.1186/s12883-021-02160-5

Ejemplares similares